14-day Premium Trial Subscription Try For FreeTry Free
$40.86
+1.51 (+3.84%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $35.67 $41.67 Thursday, 2nd May 2024 CLDX stock ended at $40.86. This is 3.84% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 5.68% from a day low at $38.75 to a day high of $40.95.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Jan 18, 2022 $31.23 $32.10 $30.53 $31.06 839 700
Jan 14, 2022 $29.98 $31.94 $28.94 $31.91 956 400
Jan 13, 2022 $31.16 $32.67 $29.94 $30.12 614 800
Jan 12, 2022 $35.17 $35.89 $31.13 $31.44 760 500
Jan 11, 2022 $35.49 $36.11 $34.96 $35.14 341 000
Jan 10, 2022 $36.30 $36.31 $34.80 $35.38 794 300
Jan 07, 2022 $35.93 $37.35 $35.79 $36.56 572 900
Jan 06, 2022 $36.58 $37.42 $34.77 $35.88 417 700
Jan 05, 2022 $39.01 $39.84 $36.61 $36.69 687 600
Jan 04, 2022 $39.18 $39.50 $37.77 $39.32 453 709
Jan 03, 2022 $39.06 $39.72 $38.17 $39.18 315 319
Dec 31, 2021 $39.15 $39.74 $37.90 $38.64 837 801
Dec 30, 2021 $39.21 $40.38 $38.70 $38.90 247 740
Dec 29, 2021 $40.54 $41.00 $38.26 $39.09 283 302
Dec 28, 2021 $41.52 $41.95 $40.44 $40.76 538 062
Dec 27, 2021 $41.78 $42.46 $40.62 $41.83 456 158
Dec 23, 2021 $40.25 $42.11 $39.50 $42.00 431 662
Dec 22, 2021 $39.15 $41.19 $38.76 $40.26 458 918
Dec 21, 2021 $39.67 $39.67 $38.31 $39.35 334 001
Dec 20, 2021 $37.92 $39.69 $36.49 $39.12 636 317
Dec 17, 2021 $35.78 $39.03 $35.00 $38.73 1 557 260
Dec 16, 2021 $38.69 $38.69 $35.70 $36.00 536 555
Dec 15, 2021 $37.51 $38.48 $35.66 $38.46 898 371
Dec 14, 2021 $37.41 $38.39 $36.61 $37.49 322 321
Dec 13, 2021 $36.44 $38.85 $36.01 $38.31 607 654
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT